Source of Support: None, Conflict of Interest: None
Intracavitory brachytherapy (ICBT) plays a major role in management of malignancy of cervix uterus. The amount of dose to be delivered to tumor volume depends upon the likely doses the rectum and bladder are going to receive because high doses to rectum and bladder could result in unmanageable complications. The complications depend upon the doses received by the rectum and bladder, the volume involved and the dose rates at which doses are received. Hence there is need to measure the actual doses received by the rectum and bladder during ICBT of cervix uterus.